Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
16,629,429
-
Total 13F shares
-
10,378,502
-
Share change
-
+10,358,897
-
Total reported value
-
$85,309,593
-
Put/Call ratio
-
114%
-
Price per share
-
$8.22
-
Number of holders
-
80
-
Value change
-
+$85,148,446
-
Number of buys
-
77
Institutional Holders of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) as of Q2 2024
As of 30 Jun 2024,
RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,378,502 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., MORGAN STANLEY, Soleus Capital Management, L.P., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Stonepine Capital Management, LLC, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
80
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.